Boucsein, Alisa http://orcid.org/0000-0002-6266-8802
Zhou, Yongwen http://orcid.org/0000-0002-0558-6712
Haszard, Jillian J. http://orcid.org/0000-0001-6312-7795
Jefferies, Craig A. http://orcid.org/0000-0002-0541-6094
Wiltshire, Esko J. http://orcid.org/0000-0002-8962-2708
Styles, Sara E. http://orcid.org/0000-0002-8358-881X
Crocket, Hamish R. http://orcid.org/0000-0002-7134-6776
Galland, Barbara C. http://orcid.org/0000-0002-2376-3575
Pasha, Maheen
Petrovski, Goran http://orcid.org/0000-0002-8622-2186
Paul, Ryan G.
de Bock, Martin I. http://orcid.org/0000-0003-0454-6679
Wheeler, Benjamin J. http://orcid.org/0000-0003-3348-5238
Funding for this research was provided by:
University of Otago
Article History
Received: 26 November 2023
Accepted: 4 February 2024
First Online: 7 March 2024
Declarations
:
: The diabetes technology used in this study will be provided by Medtronic, in addition to partial financial support for some aspects of staffing related to study conduct. Authors BJW, MIdB, and RGP have received past speaker honoraria and compensation for travel costs from Medtronic.
: This trial has been approved by the Southern Health and Disability Ethics Committee (2022 FULL 13508).
: Informed consent/assent to participate in this study will be obtained from all participants as per the requirements of ISO 14155:2011 and Good Clinical Practices.